The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.
Michael N. Abrams
Advertisement
Articles by Michael N. Abrams
A look back at the history of orphan drugs in the industry.
Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.
Advertisement
Latest Updated Articles
The Affordable Care Act's Impact on Innovation in BiopharmaPublished: February 1st 2014 | Updated:
- The Growing Orphan-Drug Paradigm
Published: April 1st 2012 | Updated:
A 25-Year Retrospective on Orphan DrugsPublished: August 1st 2012 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Meeting Global Demand and Delivering Faster, More Reliable Service
2
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
3
How India’s Biotech Ecosystem Is Shifting Toward Innovation and Global Partnerships
4
Managing Risk and Minimizing the Complexity of Your Global Single-Use Supply Chain
5
